PhaseBio Pharmaceuticals, Inc.
PHAS · NASDAQ
6/30/2022 | 3/31/2022 | 12/31/2021 | 9/30/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$17 | -$11 | $88 | -$32 |
| Dep. & Amort. | $1 | $1 | $1 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $1 | $1 | $0 | $1 |
| Change in WC | $10 | -$9 | $8 | $20 |
| Other Non-Cash | -$5 | -$4 | -$117 | $5 |
| Operating Cash Flow | -$10 | -$23 | -$20 | -$6 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$2 | -$1 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$0 | -$0 | -$2 | -$1 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $1 | $1 | $0 | -$0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$0 | -$0 | $7 | -$1 |
| Financing Cash Flow | -$0 | -$0 | $7 | -$1 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$11 | -$23 | -$15 | -$8 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $19 | $42 | $56 | $64 |
| End Cash | $8 | $19 | $42 | $56 |
| Free Cash Flow | -$10 | -$23 | -$22 | -$7 |